Disease Prevention
Michael Reid
Disease Prevention
06/21/2022
In this podcast, Michael Reid, MD, from University of California, San Francisco, discusses the newest HIV-TB prevention therapies, the latest research on a new tuberculosis vaccine, and more.
06/21/2022
prevention
Raphael Landovitz, MD
prevention
04/11/2022
In this podcast, Dr Landovitz discusses the findings from his recent trial, HPTN 083, which indicates that long-acting cabotegravir injected once every 8 weeks is superior to daily oral TDF/FTC in the...
04/11/2022
treatment
Brooke Nichols
treatment
03/17/2022
In this podcast, Brooke Nichols, PhD, answers our questions about her team's novel and pragmatic metric to evaluate and compare pre-exposure prophylaxis program effectiveness using routine implementation...
03/17/2022
HIV Prevention
Daniel Kuritzkes
HIV Prevention
10/14/2021
He talks about HIV resistance in the context of pre-exposure prophylaxis use, how common it is, and how PrEP might influence subsequent therapies.
10/14/2021
HIV Prevention
Hyman Scott, MD
HIV Prevention
07/20/2018
Dr Hyman Scott from the UCSF-Glastone Center for AIDS Research discusses pre-exposure prophylaxis (PrEP) therapy, its indications, and clinical data surrounding its use.
07/20/2018